Personal profile
Fingerprint
Dive into the research topics where Francisco Bosch Albareda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia
Medina-Gil, D., Palomo, L., Navarro, V., Lázaro, G., Martín-Mur, B., Hernández, C., Castells, O., Sánchez, B., Muñoz-Torres, P. M., Pagès, C., Pujadas, G., Esteve-Codina, A., Cabirta, A., Ferrà, C., Alcoceba, M., Terol, M. J., Andreu, R., Martí, M., Abrisqueta, P. & Bosch, F. & 1 others, , Aug 2025, In: Haematologica. 110, 8, p. 1758-1773 16 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders
Serna, Á., Navarro Garcés, V., Jiménez, M., Iraola-Truchuelo, J., Bosch, M., García, C., Falcó Roget, A., Albasanz, A., Ruiz-Camps, I., Andrés, C., Antón Pagarolas, A., Esperalba, J., Ferrero, A., García González, T., Carpio Segura, C. D. C., Crespo Maull, M., Iacoboni, G., Marín-Niebla, A., Bosch, F. & Abrisqueta, P., 26 Aug 2025, In: Blood advances. 9, 16, p. 4180-4189 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Link opens in a new tab Citations (Scopus) -
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment
Iacoboni, G., Navarro Garcés, V., Sesques, P., Rejeski, K., Bastos-Oreiro, M., Serpenti, F., Martin Lopez, A. A., Iraola-Truchuelo, J., Delgado, J., Perez, A., Guerreiro, M., Caballero, A. C., Martínez Cibrián, N., Luzardo Henriquez, H., Sanchez Pina, J. M., Sancho, J.-M., Ghesquieres, H., Mussetti, A., Lopez Corral, L. & Hernani, R. & 11 others, , 2024, In: Journal of Hematology and Oncology. 17, 1Research output: Contribution to journal › Article › Research › peer-review
Open Access9 Link opens in a new tab Citations (Scopus) -
Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE) : an open-label, phase 2a dose-finding study
Salamero, O., Molero, A., Pérez-Simón, J. A., Arnan, M., Coll, R., Garcia-Avila, S., Acuña-Cruz, E., Cano, I., Somervaille, T. C. P., Gutierrez, S., Arévalo, M. I., Xaus, J., Buesa, C., Limón, A., Faller, D. V., Bosch, F. & Montesinos, P., 2024, (Accepted in press) In: The Lancet Haematology. 11, 7, p. #e487-e498Research output: Contribution to journal › Article › Research › peer-review
Open Access10 Link opens in a new tab Citations (Scopus) -
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL) : GELLC-7 trial from the Spanish group of CLL (GELLC)
Abrisqueta, P., González-Barca, E., Ferrà, C., Ríos-Herranz, E., Fernández de la Mata, M., Delgado, J., Andreu, R., Hernández-Rivas, J. Á., Terol, M. J., Navarro, A., Vidriales, M. B., Baltasar, P., De la Serna, J., Ramírez, Á., Ballester, C., Moreno, C., García-Marco, J. A., Córdoba, R., Yáñez, L. & Casado, L. F. & 2 others, , 2024, In: EClinicalMedicine. 73Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)